These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. [Quality control of "trypsin for cell culture"]. Welke G; Dresenkamp B Arch Exp Veterinarmed; 1988 Mar; 42(2):302-7. PubMed ID: 3395186 [No Abstract] [Full Text] [Related]
69. In vitro culture of primary plasmacytomas requires stromal cell feeder layers. Degrassi A; Hilbert DM; Rudikoff S; Anderson AO; Potter M; Coon HG Proc Natl Acad Sci U S A; 1993 Mar; 90(5):2060-4. PubMed ID: 8446628 [TBL] [Abstract][Full Text] [Related]
70. The human tumor cloning assay in cancer drug development. A review. Agre P; Williams TE Invest New Drugs; 1983; 1(1):33-45. PubMed ID: 6381376 [TBL] [Abstract][Full Text] [Related]
71. Inhibition of lymphocyte mitogenesis by factor(s) released from macrophages isolated from ascitic fluid of advanced ovarian cancer patients. Sheid B; Boyce J Cancer Immunol Immunother; 1984; 17(3):190-4. PubMed ID: 6332671 [TBL] [Abstract][Full Text] [Related]
72. Long-term establishment of a human plasmacyte cell line derived from a patient with IgD multiple myeloma. I. Requirement of a plasmacyte-stimulating factor for the proliferation of myeloma cells in tissue culture. Jobin ME; Fahey JL; Price Z J Exp Med; 1974 Aug; 140(2):494-507. PubMed ID: 4858717 [TBL] [Abstract][Full Text] [Related]
73. Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas. Van Snick J; Vink A; Cayphas S; Uyttenhove C J Exp Med; 1987 Mar; 165(3):641-9. PubMed ID: 3493321 [TBL] [Abstract][Full Text] [Related]
75. Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines. Shimizu S; Yoshioka R; Hirose Y; Sugai S; Tachibana J; Konda S J Exp Med; 1989 Jan; 169(1):339-44. PubMed ID: 2783335 [TBL] [Abstract][Full Text] [Related]
76. The requirement of an adherent cell substratum for the growth of developing plasmacytoma cells in vivo. Cancro M; Potter M J Exp Med; 1976 Dec; 144(6):1554-67. PubMed ID: 1003103 [TBL] [Abstract][Full Text] [Related]
77. New concepts in the pathogenesis of primary and secondary amyloid disease. Scheinberg MA; Cathcart ES Clin Exp Immunol; 1978 Jul; 33(1):185-90. PubMed ID: 361316 [TBL] [Abstract][Full Text] [Related]
78. Primary bioassay of human myeloma stem cells. Hamburger A; Salmon SE J Clin Invest; 1977 Oct; 60(4):846-54. PubMed ID: 302265 [TBL] [Abstract][Full Text] [Related]
79. Differential stimulation of murine lymphoma growth in vitro by normal and BCG-activated macrophages. Nathan CF; Terry WD J Exp Med; 1975 Oct; 142(4):887-902. PubMed ID: 170358 [TBL] [Abstract][Full Text] [Related]
80. Immunocytology of cultured IgM-forming cells of mouse. I. Requirement of phagocytic cell factor for the growth of IgM-forming tumor cells in tissue culture. Namba Y; Hanaoka M J Immunol; 1972 Dec; 109(6):1193-200. PubMed ID: 4343748 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]